BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22508880)

  • 1. A generalized annular eruption with occasional vesicles.
    Kleker BM; Ramirez-Fort MK; Puchalsky D; Longley BJ; Swanson A; Zone J
    Arch Dermatol; 2012 Apr; 148(4):531-6. PubMed ID: 22508880
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3.
    Ansai O; Shimomura Y; Fujimoto A; Sakai A; Tsuchida Y; Hayashi R; Shigehara Y; Hama N; Abe R
    J Dermatol; 2017 Jan; 44(1):104-105. PubMed ID: 27177601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
    Brod C; Fierlbeck G; Metzler G; Sönnichsen K; Röcken M; Schaller M
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):280-2. PubMed ID: 16370478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermpath & Clinic: Pemphigus herpetiformis with vacuolar interface dermatitis and autoantibodies against desmoglein 1 and 3.
    Van Rhijn BD; Van Der Schaft J; Horvath B; Van Dijk MR; Pas HH
    Eur J Dermatol; 2021 Jun; 31(3):433-435. PubMed ID: 34309538
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
    Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
    Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemphigus herpetiformis: from first description until now.
    Kasperkiewicz M; Kowalewski C; Jabłońska S
    J Am Acad Dermatol; 2014 Apr; 70(4):780-787. PubMed ID: 24472428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
    Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
    Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pemphigus herpetiformis with absence of antibodies to desmogleins 1 and 3.
    Miura T; Kawakami Y; Oyama N; Ohtsuka M; Suzuki Y; Ohyama B; Hashimoto T; Motoki Y; Yamamoto T
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):101-3. PubMed ID: 20050294
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
    Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
    J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions.
    Prado R; Brice SL; Fukuda S; Hashimoto T; Fujita M
    Arch Dermatol; 2011 Jan; 147(1):67-71. PubMed ID: 21242397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
    Laffitte E; Panizzon RG; Borradori L
    Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
    Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
    J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant facial pemphigus vulgaris: correlation of skin lesions with the ratio of antidesmoglein antibodies 1 and 3.
    Fujii M; Honma M; Iinuma S; Kaneta K; Komatsu S; Sato K; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Apr; 36(3):284-7. PubMed ID: 21418270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoserological analyses of 55 patients with pemphigus at the Dermatological Department of Kurume University Hospital: an 11-year retrospective study (1996-2006).
    Ishii N; Maeyama Y; Karashima T; Nakama T; Kusuhara M; Yasumoto S; Hashimoto T
    Int J Dermatol; 2008 Dec; 47(12):1321-2. PubMed ID: 19126032
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris.
    Weitz D; Bystryn JC
    Arch Dermatol; 2007 Aug; 143(8):1073-4. PubMed ID: 17709673
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab in pemphigus foliaceous with autoantibodies against both Desmoglein 1 and Desmoglein 3.
    Carvalho R; Maio P; Cunha D; Freitas I; Afonso A; Cardoso J
    Eur J Dermatol; 2011; 21(3):415-6. PubMed ID: 21527367
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
    Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pruritic Blistering Eruption: Answer.
    Abbas A; Flowers RH; Noland MB; Gru AA
    Am J Dermatopathol; 2020 Feb; 42(2):144-145. PubMed ID: 31990703
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed immunologic evidence in pemphigus vulgaris.
    Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1092-3. PubMed ID: 19207659
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
    Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
    J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.